Quote:
Originally Posted by Apia resurrected
Chemda here some inside from big pharma:
Pauses in trials are common because the safety regulations are so strict.
You just dont hear about them because no one cared before covid and because it doesn't fit to the very bad image of pharma.
Even with drugs on the market I have to report everything.
When someone takes our heart drug and in that time his feet grow a size or his fingernails get darker I have to report it even if the link to the drug is unlikely. If I dont do it and it comes out I would be in huge trouble.
The company has to do it to be safe and not to get sued.
Same with trials.
|
Here is a good article from the NYT about it.
https://www.nytimes.com/2020/10/14/h...al-trials.html
It’s especially good, because it confirms what I said here and makes me feel smart.